PofoliaShared via Pofolia

Alzheimer s & Dementia· 2016Q1

Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early‐stage biomarker discovery

Panos Theofilas, Alexander J. Ehrenberg, Sara Dunlop, Ana Tereza Di Lorenzo Alho et al.

Short summary

Locus coeruleus (LC) volume decreases by 8.4% per Braak stage increase in Alzheimer's disease (AD), with neuronal loss only appearing midway through progression.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Locus coeruleus (LC) volume decreases by 8.4% for each Braak stage increase in Alzheimer's disease.
  • Significant neuronal loss in the LC is observed only midway through AD progression.
  • Age-related changes do not significantly affect LC volume.
  • The findings suggest a potential delay between neurofibrillary tangle accumulation and neuronal death in the LC.

AI-generated from the title and abstract; the full text is not read.

Abstract

INTRODUCTION: Alzheimer's disease (AD) progression follows a specific spreading pattern, emphasizing the need to characterize those brain areas that degenerate first. The brainstem's locus coeruleus (LC) is the first area to develop neurofibrillary changes (neurofibrillary tangles [NFTs]). METHODS: The methods include unbiased stereological analyses in human brainstems to estimate LC volume and neuronal population in controls and individuals across all AD stages. RESULTS: As the Braak stage increases by 1 unit, the LC volume decreases by 8.4%. Neuronal loss started only midway through AD progression. Age-related changes spare the LC. DISCUSSION: The long gap between NFT accumulation and neuronal loss suggests that a second trigger may be necessary to induce neuronal death in AD. Imaging studies should determine whether LC volumetry can replicate the stage-wise atrophy observed here and how these changes are specific to AD. LC volumetry may develop into a screening biomarker for selecting high-yield candidates to undergo expensive and less accessible positron emission tomography scans and to monitor AD progression from presymptomatic stages.

The authors' abstract, as published at the source. Alzheimer s & Dementia, 2016 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Applied Mathematics

Applied MathematicsMathematics